Liminatus Pharma, Inc. (LIMN)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Feb. 11, 2026 | CORRESP | Neutral/Informational | Moderate | Liminatus Pharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. They are seeking to have the stat… | Read Filing EDGAR |
| Feb. 11, 2026 | CORRESP | Neutral/Informational | Moderate | Liminatus Pharma, Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-1. The request, made by Maxim Group LLC as the pl… | Read Filing EDGAR |
| Jan. 6, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Liminatus Pharma, Inc. that they do not intend to review the company's draft registration statement submitted on December 31, 2025. The SEC has request… | Read Filing EDGAR |
| Aug. 11, 2025 | CORRESP | Neutral/Informational | High | Liminatus Pharma, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1. The company aims for the statement… | Read Filing EDGAR |
| Jul. 25, 2025 | CORRESP | Neutral/Informational | Moderate | Liminatus Pharma, Inc. has submitted a response to the SEC's comments regarding their Registration Statement on Form S-1, originally filed on June 24, 2025. The correspondence inc… | Read Filing EDGAR |
| Jul. 3, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has conducted a limited review of Liminatus Pharma, Inc.'s registration statement filed on June 24, 2025, and has issued comments requiring clarification and additional in… | Read Filing EDGAR |